Alvotech (ALVO) Income from Non-Controlling Interests (2024 - 2025)
Alvotech (ALVO) posted Income from Non-Controlling Interests of -$3.0 million for Q3 2025, little changed on a QoQ basis from -$3.0 million in Q4 2024.
Alvotech (ALVO) Income from Non-Controlling Interests (2024 - 2025) Analysis & Trends
Alvotech's Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at -$3.0 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Alvotech | 916.74 Mn | 916.74 Mn | 5.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.97 Mn |
| Dec 31, 2024 | -2.97 Mn |